Identifikujte potencijalne rizike, neusklađenosti i upozorenja u svim tenderskim dokumentima. Dobijte detaljan izveštaj o rizicima sa nivoima ozbiljnosti i preporukama za ublažavanje.
Prijavite seDobijte AI strategiju za pobedu prilagođenu ovom tenderu. Uključuje ocenu verovatnoće pobede, ključne prilike i izazove, preporučene oblasti fokusa za ponudu, uvide u konkurentsko pozicioniranje i konkretne preporuke za maksimiziranje vaših šansi.
Prijavite seNadogradite da biste videli koje kompanije će se verovatno nadmetati na ovom tenderu, na osnovu istorijskih podataka o javnim nabavkama.
Prijavite se9 zahteva u 5 kategorija
Registrujte se da biste videli potpune zahteve i analizu
Dobijte AI-generisane sažetke svih tenderskih dokumenata. Brzo razumejte šta svaki dokument sadrži bez čitanja stotina stranica — uključujući obim, uslove, kriterijume evaluacije i ključne obaveze.
Prijavite seThis tender is generally well-structured with a clear description and substantial estimated value, but lacks specific details on evaluation criteria and technical/financial requirements.
The tender follows an open procedure and specifies a CPV code for pharmaceutical products. Deadlines appear reasonable given the active status and submission date. No disputes are noted. The procedure is described as 'competition' which is a bit vague but acceptable. Regulatory compliance is assumed unless otherwise indicated.
The description of Amgros I/S and its purpose is clear. The nature of the framework agreements (non-exclusive, no purchase obligation) is well-defined. However, the absence of specified evaluation criteria and detailed technical/financial requirements reduces overall clarity.
Basic information such as title, reference, organization, estimated value, and deadline are present. Two tender documents are indicated. However, crucial details like contract duration, specific technical and financial requirements, and the content of the attached documents are not fully accessible or detailed in the provided summary.
The tender is an open procedure, and the framework agreements are non-exclusive, promoting broad participation. The estimated value is disclosed. The lack of specific tailored requirements for particular companies suggests good fairness. However, the absence of detailed evaluation criteria could be a concern for bidders.
The tender is marked as 'E-Procurement', suggesting electronic submission is possible. However, the 'Issues' section notes 'No e-submission', which is contradictory and a significant concern. The contract start date is not specified, and financing information is absent. The duration of the contract is also missing.
Key fields like title, reference, organization, value, and deadline are populated. There are no reported suspensions or disputes. Dates are logical, with the submission deadline well into the future from the publication date. The 'active' status is consistent with an upcoming deadline.
There is no explicit mention of green procurement, social aspects, or innovation within the provided tender information. This suggests a lack of focus on these areas.
Registrujte se da biste videli potpune zahteve i analizu
Nije potrebna kreditna kartica • Podešavanje za 2 minuta
Naši stručnjaci za javne nabavke pripremaju sve. Dokazano efikasno — Vi pregledate, odobrite i predate.
Poštovani! Ja sam vaš AI asistent za ovaj tender. Mogu vam pomoći da razumete zahteve, rokove, kriterijume za ispunjenost uslova i pružiti strateške uvide.
Nije potrebna kreditna kartica